Skip to content

Hemab Therapeutics Holdings

US · COAG #3007 by market cap Listed 2026
39.29 -0.57 -1.43%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 5 analysts

Buy
Avg price target 64.00 +62.9%
Price target rangecurrent 39.29
Low56.00
Avg64.00
High70.00
Buy 100% Hold 0% Sell 0%
Recent ratings (19)
DateFirmAnalystRatingTarget
2026-11-11 Evercore -- Buy 65.00
2026-11-09 LifeSci Capital -- Buy 65.00
2026-11-05 Wedbush -- Buy 64.00
2026-10-15 J.P. Morgan -- Buy 70.00
2026-10-12 Rodman & Renshaw -- Buy 56.00
2026-08-12 Wedbush -- Buy 64.00
2026-08-11 H.C. Wainwright -- Buy 60.00
2026-07-13 Wedbush -- Buy 55.00
2026-07-13 Jefferies -- Buy 47.00
2026-07-13 Goldman Sachs -- Buy 46.00
2026-07-13 H.C. Wainwright -- Buy 52.00
2026-06-29 Wedbush -- Buy 42.00
2026-06-26 H.C. Wainwright -- Buy 40.00
2026-06-17 H.C. Wainwright -- Buy 40.00
2026-06-08 Jefferies -- Buy 39.00
2026-05-26 Wedbush -- Buy 42.00
2026-05-26 Jefferies -- Buy 39.00
2026-05-26 Evercore -- Buy 50.00
2026-05-26 Goldman Sachs -- Buy 36.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Hemab Therapeutics Holdings discussion 0 comments

Add a comment